COVID-19 WebinarsGlobal Health

COVID-19: The Invisible Impact on Team Members

By May 19, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

This webinar was previously recorded on May 13th, 2020 and is now available on demand.
Join colleagues and thought leaders as we examine the emotional and logistical impact of COVID-19 on employees. Panelists will discuss job loss, mental wellbeing, employee’s top concerns and communication surrounding the global coronavirus pandemic.
Experts will discuss ways to offset anxiety and depression, steps to take care of your emotional well-being and logistical challenges such as homeschooling and balancing the ever-changing priorities during this crisis. There will also be discussion surrounding manager communication strategies, what works, what does not work and ways employers can calm employee’s fears during the pandemic.

Moderator

  • Brandon Thompson
    (Co-Founder, Careers in Aesthetics & Co-Founder & CEO, BNB Aesthetic Innovations)

Faculty

  • Richard G. Fried, MD, PhD
    (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)
  •  John Connors
    (CEO & President, Jan Marini Skin Research)
  •  Mark Wilkins
    (Executive Vice President and U.S. General Manager, Prollenium Medical Technologies)
  •  Aaron Burton
    (CEO, Sciton)
  •  Jenna Mons Anderson
    (CEO, AccessElite)

You May Also Like

Journal of Drugs in Dermatology JDD Article About Hypochlorous Acid for a Persistent Filler Nodule: A Case ReportCase ReportsFeatured ArticlesLatest NewsMedical DermThe Latest
September 3, 2025

Hypochlorous Acid for a Persistent Filler Nodule: A Case Report

Biofilms, Hard Nodules, and the Surprising Power of Hypochlorous Acid Most hyaluronic acid lumps after filler settle on their own, but a rare “delayed-onset” nodule can spell trouble—especially when it…
Journal of Drugs in Dermatology JDD Interview with Dr. Christopher Bunick: An In-Depth Interview Focusing on Atopic Dermatitis and the LEVEL UP Period 2 DataAtopic DermatitisFeatured ArticlesLatest NewsThe Latest
September 2, 2025

JDD Interview with Dr. Christopher Bunick: An In-Depth Interview Focusing on Atopic Dermatitis and the LEVEL UP Period 2 Data

Switching from Dupilumab to Upadacitinib: Practice-Informing Evidence from LEVEL UP SWITCH This exclusive video interview with Dr. Christopher Bunick unveils the practice-changing insights of the LEVEL UP SWITCH study, designed…
Journal of Drugs in Dermatology JDD Article About The Impact of an AGE-Inhibiting Moisturizer on Procedure EffectivenessFeatured ArticlesLatest NewsSkincareThe Latest
August 28, 2025

The Impact of an AGE-Inhibiting Moisturizer on Procedure Effectiveness

Harness the Power of AGE Inhibition for Superior Post-Resurfacing Results A breakthrough split-face study shows that a targeted AGE-inhibitory moisturizer dramatically elevates post-resurfacing skincare outcomes for all skin tones. After…

Leave a Reply